Cantitate/Preț
Produs

Advancing Gene Fusion Detection Towards Personalized Cancer Nanodiagnostics: Springer Theses

Autor Kevin M. Koo
en Limba Engleză Hardback – 7 oct 2019
This book presents a unique concept of merging nanotechnology and novel urinary biomarkers for accurate early prostate cancer detection, discussing an entire progressive pipeline of innovative new strategies in biosensor development, from a simple colorimetric system to a complex system for simultaneous multiple biomarker sensing. For newcomers to the field of nucleic acid biosensing, it also describes various isothermal amplification and amplification-free strategies, which are currently the main research areas. Lastly, the book introduces and demonstrates the notion of clinical nanobiosensor validation toward clinical translation: the ultimate aim of researchers in the biosensor field. This book is a valuable reference resource learners seeking inspiration for cancer biosensor development.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 61363 lei  6-8 săpt.
  Springer International Publishing – 7 oct 2020 61363 lei  6-8 săpt.
Hardback (1) 61952 lei  6-8 săpt.
  Springer International Publishing – 7 oct 2019 61952 lei  6-8 săpt.

Din seria Springer Theses

Preț: 61952 lei

Preț vechi: 72885 lei
-15% Nou

Puncte Express: 929

Preț estimativ în valută:
11858 12358$ 9871£

Carte tipărită la comandă

Livrare economică 04-18 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783030309992
ISBN-10: 3030309991
Pagini: 102
Ilustrații: XIII, 102 p.
Dimensiuni: 155 x 235 mm
Greutate: 0.35 kg
Ediția:1st ed. 2019
Editura: Springer International Publishing
Colecția Springer
Seria Springer Theses

Locul publicării:Cham, Switzerland

Cuprins

Unifying Next-Generation Biomarkers and Nanodiagnostic Platforms for Precision Prostate Cancer (PCa) Management.- Colorimetric Gene Fusion Diagnostics for Visual Binary Readout.- Label –Free Surface-Enhanced Raman Scattering Detection System for Clinical Biomarker Targets.- Amplification-Free Electrochemical RNA Biomarker Sensing.- Simultaneous Analysis of Multiple Biomarkers via High-Throughput Parallel Profiling.


Textul de pe ultima copertă

This book presents a unique concept of merging nanotechnology and novel urinary biomarkers for accurate early prostate cancer detection, discussing an entire progressive pipeline of innovative new strategies in biosensor development, from a simple colorimetric system to a complex system for simultaneous multiple biomarker sensing. For newcomers to the field of nucleic acid biosensing, it also describes various isothermal amplification and amplification-free strategies, which are currently the main research areas. Lastly, the book introduces and demonstrates the notion of clinical nanobiosensor validation toward clinical translation: the ultimate aim of researchers in the biosensor field. This book is a valuable reference resource learners seeking inspiration for cancer biosensor development.

Caracteristici

Nominated as an outstanding PhD thesis by the Australian Institute for Bioengineering and Nanotechnology Describes the design of various novel nano-strategies for prostate cancer detection Offers an extensive investigation into the use of next-generation urinary biomarkers Includes data on clinical evaluation to progress clinical translation